What is Trigyn Technologies Ltd (TRIGYN) share price return in the past 10 years?

Trigyn Technologies Ltd share price has declined -7.2% annually (CAGR) over the past ten years.

What is the share price of Trigyn Technologies Ltd (TRIGYN)?

Company share prices are keep on changing according to the market conditions. The current trading price of Trigyn Technologies Ltd (TRIGYN) on 07-Oct-2026 16:01:00 at 16:01 is 51.25.

What is the P/E ratio of Trigyn Technologies?

The latest standalone P/E ratio of Trigyn Technologies as of 07-Oct-2026 is 19.45.

What is the P/B ratio of Trigyn Technologies Ltd (TRIGYN)?

The latest standalone P/B ratio of Trigyn Technologies Ltd (TRIGYN) as of 07-Oct-2026 is 0.78.

What is the 52-week high and low of Trigyn Technologies Ltd (TRIGYN)?

The 52-week high of Trigyn Technologies Ltd (TRIGYN) is Rs. 84.00 and the 52-week low is Rs. 37.33.

Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2021-22	1	1
2	2022-23	1	1
3	2023-24	0	0
4	2024-25	0	0
	Grand Total	2	2

Trigyn Technologies Ltd (TRIGYN)

Name: Trigyn Technologies Ltd (TRIGYN)
Brand: Trigyn Technologies

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 517562 NSE: TRIGYN IT - Software | Small Cap | Trigyn Technologies Share Price

₹51.25 -0.41 (-0.79%)

As on 07-Oct'26 16:01

Trigyn Technologies Ltd (TRIGYN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 517562 NSE: TRIGYN IT - Software | Small Cap | Trigyn Technologies Share Price

₹51.25 -0.41 (-0.79%)

As on 07-Oct'26 16:01

Key Metrics

Valuation Multiples

Market Cap

₹159 Cr.

Current Price

₹51.3

52-Week Low / High

₹37 / 84

TTM EPS

₹3.3

TTM Sales

₹1,005 Cr.

Book Value per Share

₹259.9

P/E Ratio

15.77

Lower than its 5-year historical median

Industry PE

20.1

Price to Book (P/B)

0.20

Lower than its 5-year historical median

Price to Sales (P/S)

0.16

Lower than its 5-year historical median

EV/EBITDA

-11.57

Lower than its 5-year historical median

Dividend Yield

Profitability Efficiency

Return on Equity (ROE)

0.30%

Underperforms industry median

Return on Capital Employed (ROCE)

2.06%

Underperforms industry median

Return on Assets (ROA)

0.24%

Operating Profit Margin

0.8%

Net Profit Margin

0.24%

Gross Profit Margin

1.9%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

23.43%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-81.2%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-82.64%

Asset Quality

Promoter Holding

44.51%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹769 Cr.

Equity

₹30.8 Cr.

Face Value

₹10

All Time Low / High

₹5.80 / 3101.95

Trigyn Technologies stock performance

Key Ratios

Check Before You Invest

Quality

Somewhat Good

Check detailed performance

Valuation

Undervalued

Check Valuation charts

Price Trend

Weak

Check Price chart

Q.1 Is Trigyn Technologies Ltd a good quality company?

Trigyn Technologies Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Trigyn Technologies Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Trigyn Technologies Ltd vs industry peers?

Trigyn Technologies Ltd revenue CAGR is -0.18%, compared to the industry median CAGR of 0.00%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Trigyn Technologies Ltd?

Promoters hold 44.51% of the Trigyn Technologies Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Trigyn Technologies Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -7.1% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
ROCE % ⓘ	1%	0.7%	8.1%	6.8%	4%	2.9%	4.5%	5.3%	4.7%	9.9%	-
Value Creation Index ⓘ	-0.9	-1.0	-0.4	-0.5	-0.7	-0.8	-0.7	-0.6	-0.7	-0.3	-
Growth Parameters ⓘ
Sales ⓘ	55.8	61.8	129	76.2	88.2	94.3	173	175	153	189	192
Sales YoY Gr.	-	10.8%	108.4%	-40.8%	15.7%	6.8%	83%	1.6%	-12.7%	23.4%	-
Adj EPS ⓘ	0.6	0.2	2.3	1.9	1.1	0.3	1.9	2.4	1.2	3.1	2.7
YoY Gr.	-	-76.6%	1420%	-17.1%	-44.4%	-72.4%	548.3%	26.6%	-49.6%	160.8%	-
BVPS (₹) ⓘ	56.5	56.8	58.2	59.2	60.1	60.3	61.5	61.2	66	67.4	66.6
Adj Net Profit ⓘ	1.9	0.5	7	5.8	3.2	0.9	5.8	7.3	3.7	9.6	8
Cash Flow from Ops. ⓘ	-1	1.6	-10.3	2	-3.8	-9.9	-5.5	-5.8	-6	-19.4	-
Debt/CF from Ops. ⓘ	-0.5	0.5	-1.2	5.6	-2.2	-0.5	-0.4	-0	-1.5	-0.3	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	14.5%	16.5%	3.1%	23.4%
Adj EPS ⓘ	19.3%	24.4%	18.5%	160.8%
BVPSⓘ	2%	2.3%	3.1%	2.1%
Share Price	-7.2%	-15.5%	-26.1%	-35.6%

Key Financial Parameters ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
Return on Equity % ⓘ	1.1	0.3	4	3.2	1.8	0.5	3.1	3.9	1.9	4.7	4
Op. Profit Mgn % ⓘ	3.2	2.8	10.1	-2.5	3.5	-9.3	-6.7	-8.7	-0.7	7.7	4.9
Net Profit Mgn % ⓘ	3.4	0.8	5.4	7.6	3.7	0.9	3.4	4.2	2.4	5.1	4.3
Debt to Equity ⓘ	0	0	0.1	0.1	0.1	0	0	0	0	0	-
Working Cap Days ⓘ	577	550	303	544	490	484	310	384	453	381	136
Cash Conv. Cycle ⓘ	240	159	63	224	259	228	113	108	141	135	45

Valuation of Trigyn Technologies - Consolidated

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Sales	679	685	895	911	985	1,041	1,273	1,280	898	976
Operating Expenses > ⓘ +	614	624	810	833	893	975	1,212	1,245	878	973
Manufacturing Costs	2	129	4	3	3	4	24	32	17	33
Material Costs	2	8	58	13	17	3	34	16	1	0
Employee Cost	456	460	534	588	651	693	786	790	477	477
Other Costs > ⓘ	154	27	214	228	223	275	368	407	383	462
Operating Profit > ⓘ	65	61	84	77	92	65	61	35	19	4
Operating Profit Margin (%)	9.6%	8.9%	9.4%	8.5%	9.4%	6.3%	4.8%	2.7%	2.2%	0.4%
Other Income > ⓘ +	3	1	1	5	3	3	6	12	18	17
Exceptional Items > ⓘ	-0	0	-5	0	0	0	0	0	-1	-2
Interest > ⓘ	1	1	1	2	3	3	2	2	3	3
Depreciation > ⓘ	1	1	1	2	3	7	7	7	5	3
Profit Before Tax > ⓘ	66	60	78	78	89	59	58	38	28	13
Tax > ⓘ	27	20	30	28	27	20	24	18	15	11
Profit After Tax	39	39	48	50	62	39	35	20	13	2
PAT Margin (%)	5.8%	5.8%	5.4%	5.5%	6.3%	3.8%	2.7%	1.6%	1.5%	0.2%
Adjusted EPS (₹)	13.1	13.2	15.7	16.3	20.2	12.7	11.3	6.5	3.8	0.7
Dividend Payout Ratio (%)	0%	0%	4.80%	1.50%	0%	0%	0%	0%	0%	0%

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Equity and Liabilities
Shareholders Fund +	324	366	433	503	558	607	681	701	741	797
Share Capital ⓘ	29.74	29.90	30.78	30.79	30.79	30.79	30.79	30.79	30.79	30.79
Reserves ⓘ	295	336	402	473	527	577	650	670	710	766
Debt +	0	0	8	6	8	5	2	0	9	6
Long Term Debt	0	0	8	6	4	0	0	0	0	0
Short Term Debt	0	0	0	0	4	5	2	0	9	6
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	37	53	65	72	77	84	98	80	70	91
Others Liabilities ⓘ	33	36	39	43	52	71	87	100	105	109
Total Liabilities ⓘ	395	455	545	624	695	768	868	881	925	1,003
Fixed Assets
Net Fixed Assets ⓘ +	89	90	90	100	99	108	107	103	97	96
Gross Block	94	97	97	111	114	123	126	124	122	124
Accumulated Depreciation	5	6	8	11	15	15	19	22	25	29
CWIP ⓘ	0	0	0	1	1	1	1	0	0	0
Investments ⓘ	1	1	4	4	5	21	83	17	38	33
Inventories	0	10	1	5	3	3	11	8	9	9
Trade Receivables	127	138	194	259	241	282	305	249	244	250
Cash Equivalents ⓘ	110	123	123	130	196	215	138	336	413	474
Others Assets ⓘ	68	92	133	125	148	136	223	169	124	141
Total Assets ⓘ	395	455	545	624	695	768	868	881	925	1,003

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Cash Flow From Operating Activity ⓘ +	46	15	-18	-1	80	45	-52	126	51	-9
PBT ⓘ	66	60	78	78	89	59	58	38	26	13
Adjustment ⓘ	3	5	2	11	8	14	18	42	4	6
Changes in Working Capital ⓘ	5	-26	-84	-63	8	-4	-97	73	40	-20
Tax Paid ⓘ	-28	-24	-14	-27	-25	-23	-31	-27	-19	-8
Cash Flow From Investing Activity ⓘ +	1	-2	-3	-11	-1	-31	-63	68	16	20
Capex	-1	-3	-0	-14	-3	-16	-6	-1	-0	-2
Net Investments	0	0	0	0	-0	-17	-63	57	-2	4
Others ⓘ	2	1	-2	3	2	1	6	12	18	17
Cash Flow From Financing Activity ⓘ +	-1	-1	7	-5	-5	-6	-3	-4	-3	-3
Net Proceeds from Shares ⓘ	0	0	1	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-1	-1	-1	-2	-3	-3	-2	-2	-3	-3
Dividend Paid ⓘ	0	0	0	-2	-1	0	0	0	0	0
Others ⓘ	0	0	7	-0	-1	-3	-1	-2	-1	-0
Net Cash Flow ⓘ	47	13	-13	-17	74	8	-118	191	64	8

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Ratios
ROE (%)	12.75	11.44	12.13	10.7	11.72	6.71	5.38	2.89	1.87	0.3
ROCE (%)	21.78	17.36	19.47	16.65	16.96	10.45	9.34	5.76	4.25	2.06
Asset Turnover Ratio	1.81	1.61	1.79	1.56	1.49	1.42	1.56	1.46	0.99	1.01
PAT to CFO Conversion(x)	1.18	0.38	-0.38	-0.02	1.29	1.15	-1.49	6.3	3.92	-4.5
Working Capital Days
Receivable Days	72.50	70.70	67.70	90.80	92.80	91.70	84	79	100.20	92.30
Inventory Days	0	5.30	2.30	1.20	1.50	1.20	2	2.60	3.30	3.30
Payable Days	7,224.30	1,993.60	367.80	1,886	1,620.10	0	978.90	2,050.70	0	0

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Trigyn Technologies Ltd FAQs

The current trading price of Trigyn Technologies on 07-Oct-2026 16:01 is ₹51.25.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 06-Oct-2026 the market cap of Trigyn Technologies stood at ₹159.0 Cr

The latest P/E ratio of Trigyn Technologies as of 06-Oct-2026 is 19.45.

The latest P/B ratio of Trigyn Technologies as of 06-Oct-2026 is 0.78.

The 52-week high of Trigyn Technologies is ₹84.00 and the 52-week low is ₹37.33.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Trigyn Technologies is ₹192 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Trigyn Technologies Ltd is a average quality company.

The key valuation ratios of Trigyn Technologies Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Trigyn Technologies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Trigyn Technologies Ltd

Trigyn Technologies Ltd was incorporated on March 25, 1986 in Maharashtra as a private limited company and was converted into a public limited company on August 8, 1994. It was promoted by software professionals, Ramkrishna Bhagwat Atul Kamath & Tushar Vaidya.

Trigyn Technologies is an innovative, software-led solutions provider and systems integrator. It has software professionals on board at locations in India, the US, Europe and the Far East - working round the clock to bring cutting-edge technology. They have development centers in New Jersey, Bangalore and Mumbai, India.

Innovative products, client-specific software services and solutions, highly complex system integration projects that enable and drive client-centric convergence in enterprises. That's what Trigyn Technologies offers.

Trigyn benefits from over 20 years of experience in the information technology industry and has an established client base of major fortune 500 companies in varying industry, World Governmental Organizations, and State Governments. Trigynâ€™s impressive client base portrays their ability to work with the best and to provide effective solutions using cutting edge technologies to meet and exceed expectations.

Products and services offered by the company:

Products:

Apollo Apollo is a network independent billing application and works on the philosophy of 'Customer Empowerment'. The product is built entirely around the client, allowing the client to play a key role in planning his services & rate plans.
Global Financial Trading Suite Trigyn Technologies has developed a comprehensive range of financial solutions which provide information systems with an array of analytical, risk-eliminating, controlling and decision-making tools.
FundPro FundPro is a sophisticated package for Investment Management and Accounting catering to the needs of Mutual Funds and Insurance Companies.

Services:

Outsourcing Services

Re-engineering & Migration Practice

QA Practice

Engineering Practice

Staff Augmentation Services

ECDM Services

Documentum Practice
Governance Practice

Achievements/ recognition:

Trigyn has been awarded EMC Channel Partnership (July 04, 2008)
Trigyn was Awarded Multi-Year Solutions Provider Contract by Massachusetts (July 01, 2008)
Accreditation as â€œMicrosoft Gold Certified Partnerâ€ by Microsoft Corporation (June 23, 2008)
Trigyn was Awarded Multi-Million Dollar UN Managed Services Contract Extension (May 29, 2008)
Trigyn was Awarded Microsoft Gold Certification (April 01, 2008)
2009 - Trigyn Wins State of Texas IT Staff Augmentation Services Contract
Trigyn Wins State of South Carolina IT Temporary Staffing Services Contract
2010 Trigyn Wins 3 Commonwealth of Massachusetts Multi-Year Contracts
2011 - Trigyn Awarded Commonwealth of Massachusetts Solution Provider Contract2012
Trigyn Awarded New York City IT Services Contract Extension
Trigyn Awarded IT Staffing MSA by Fortune 500 Financial Services Company
2013 - Trigyn Awarded Washington State Contracts
2014 - Trigyn Awarded Multi-Year California IT Consulting Services MSA

You have 43 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Trigyn Technologies Ltd (TRIGYN)

Trigyn Technologies Ltd (TRIGYN)

Trigyn Technologies stock performance